Injectable, Biodegradable Bone Cements and Methods of Making and Using Same
US-2015005392-A1 · Jan 1, 2015 · US
US10342893B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10342893-B2 |
| Application number | US-201314375927-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 31, 2013 |
| Priority date | Jan 31, 2012 |
| Publication date | Jul 9, 2019 |
| Grant date | Jul 9, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.
Opening claim text (preview).
What is claimed is: 1. A bone cement composition comprising: a magnesium phosphate comprising newberyite; a biocompatible polymer; and silica sol; wherein the bone cement composition is in the form of an injectable paste or a putty. 2. The bone cement of claim 1 , wherein the biocompatible polymer comprises chitosan. 3. The bone cement of claim 1 , wherein the biocompatible polymer is surface-phosphorylated. 4. A bone cement composition comprising: a magnesium phosphate comprising newberyite; and silica sol; wherein the bone cement composition is in the form of an injectable paste or a putty. 5. The bone cement composition of claim 4 , further comprising an additive selected from the group consisting of: proteins, osteoinductive materials, osteoconductive materials, X-ray opacifying agents, medicaments, supporting or strengthening filler materials, crystal growth adjusters, viscosity modifiers, pore-forming agents, antibiotics, antiseptics, growth factors, chemotherapeutic agents, bone resorption inhibitors, color change agents, immersing liquids, carboxylates, carboxylic acids, α-hydroxyl acids, collagen, pyrophosphates, sulfates, and metallic ions. 6. The bone cement composition of claim 4 , further comprising a nonaqueous extender comprising glycerine and/or propylene glycol, wherein the bone cement composition is in the form of a putty. 7. A bone cement composition comprising: a magnesium phosphate comprising newberyite; and silica; wherein the bone cement composition is in the form of a hardened mass.
Phosphate cements (apatite A61K6/838) · CPC title
Polysaccharides · CPC title
comprising phosphorus-containing compounds · CPC title
Phosphorus-containing materials, e.g. apatite · CPC title
Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.